RetinalGenix Technologies (RTGN) Equity Ratio (2020 - 2026)

RetinalGenix Technologies has disclosed Equity Ratio across 7 years of filings, most recently posting 440.67 for Q1 2026.

• Equity Ratio for Q1 2026 came in at 440.67, down 215.22% year-over-year; the trailing twelve-month figure through Mar 2026 was 440.67 (down 215.22% YoY), and the FY2025 annual result was 109.43, down 11.83% from the prior year.
• Equity Ratio came in at 440.67 for Q1 2026 at RetinalGenix Technologies, down from 109.43 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 20.82 in Q2 2024 to a low of 25006.48 in Q2 2022.
• The 5-year median for Equity Ratio is 270.56 (2022), against an average of 2673.95.
• Across the five-year window, Equity Ratio sank 3771.23% in 2022 and surged 99.57% in 2024, its largest moves.
• RetinalGenix Technologies' Equity Ratio stood at 3636.27 in 2022, then slumped by 147.8% to 9010.62 in 2023, then soared by 98.91% to 97.86 in 2024, then declined by 11.83% to 109.43 in 2025, then plunged by 302.68% to 440.67 in 2026.
• The last three Equity Ratio figures came in at 440.67 (Q1 2026), 109.43 (Q4 2025), and 310.35 (Q3 2025), per Business Quant data.